Orchid Pharma Ltd Share Price
As on 18 November 2025 at 23:55 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
18.42%
Over 6 Months
13.08%
Over 1 Year
-39.61%
Over 3 Years
109.66%
Orchid Pharma Ltd Summary
Close ₹858.35
Open ₹806
High ₹868
Low ₹805.75
Volume 2,98,704
Net Turnover (in Cr) ₹25.4
52Wk High ₹1,997.40
52Wk Low ₹603.80
52Wk High / Low
603.80
1,997.40
Orchid Pharma Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹4,353.47
EPS (TTM) 14.23
Book Value (BV) 264.97
Div. Yield -
P/E (TTM) 60.29
Price/Book Value 3.24
Delivery % 29.34 %
Face Value 10
Key Ratios
PE Ratio 37.01
PB Ratio 3.14
EV to Sales 4.29
PEG Ratio 2.99
ROA 7.09
ROE 3.32
Debt-Equity 0.12
Net Profit Margin 11.55
Operating Profit Margin 16.90
Orchid Pharma Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 949.40 | 850.23 | 685.33 | 568.56 | 465.27 |
| Total Expenses | 853.84 | 758.29 | 669.29 | 625.46 | 560.52 |
| Profit Before Tax | 95.56 | 91.95 | 55.25 | -56.90 | -95.25 |
| Profit After Tax | 95.76 | 95.06 | 55.25 | -56.90 | -95.25 |
| Operating Profit After Depreciation | 110.10 | 108.30 | 48.26 | -24.89 | -43.91 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 648.93 | 634.51 | 573.09 | 583.70 | 670.45 |
| Total Non Current Assets | 880.50 | 763.12 | 724.20 | 712.91 | 687.39 |
| Total Current Assets | 807.42 | 790.75 | 501.01 | 397.65 | 549.86 |
| Total Assets | 1,687.91 | 1,553.87 | 1,225.21 | 1,110.56 | 1,237.25 |
| Total Shareholder's Fund | 1,267.29 | 1,169.47 | 688.65 | 647.38 | 652.91 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 19.22 | 125.99 | 18.34 | 92.47 | 23.59 |
| Net Cash Used In Investing Activities | -26.93 | -312.03 | -31.21 | 112.94 | 67.21 |
| Net Cash Used In Financing Activities | 25.22 | 167.04 | 31.17 | -216.80 | -164.99 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 953.86 | 849.76 | 685.33 | 565.98 | 457.16 |
| Total Expenses | 847.37 | 758.23 | 669.29 | 618.75 | 553.03 |
| Profit Before Tax | 106.48 | 91.52 | 55.25 | -52.77 | -95.87 |
| Profit After Tax | 106.48 | 94.75 | 55.25 | -52.77 | -95.87 |
| Operating Profit After Depreciation | 121.02 | 107.85 | 48.26 | -20.76 | -44.54 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 629.47 | 630.71 | 573.06 | 583.65 | 670.39 |
| Total Non Current Assets | 910.19 | 769.91 | 729.46 | 711.12 | 682.22 |
| Total Current Assets | 786.39 | 782.29 | 493.79 | 383.07 | 542.25 |
| Total Assets | 1,696.58 | 1,552.20 | 1,223.26 | 1,094.19 | 1,224.47 |
| Total Shareholder's Fund | 1,324.05 | 1,218.32 | 731.96 | 677.95 | 681.34 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 27.48 | 130.73 | 13.39 | 89.57 | 24.36 |
| Net Cash Used In Investing Activities | -37.35 | -315.81 | -26.70 | 112.93 | 67.21 |
| Net Cash Used In Financing Activities | 25.44 | 167.07 | 31.17 | -216.80 | -164.99 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 193.52 | 172.93 | 237.48 | 217.34 | 222.70 |
| Total Expenses | 195 | 158.76 | 209.50 | 190.98 | 192.36 |
| Profit Before Tax | -3.34 | 13.71 | 19.09 | 22.44 | 25.90 |
| Profit After Tax | -3.33 | 13.71 | 19.13 | 22.45 | 25.90 |
| Operating Profit after Depreciation | 9.29 | 25.62 | 31.88 | 34.85 | 37.86 |
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 193.52 | 172.93 | 237.48 | 217.34 | 222.70 |
| Total Expenses | 194.20 | 158.75 | 203.15 | 190.97 | 193.11 |
| Profit Before Tax | 2.23 | 18.20 | 27.85 | 23.91 | 25.62 |
| Profit After Tax | 2.23 | 18.20 | 27.85 | 23.91 | 25.63 |
| Operating Profit after Depreciation | 14.75 | 30.11 | 40.59 | 36.31 | 37.55 |
Orchid Pharma Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 820.07
S2 781.78
S3 757.82
Pivot 844.03
R1 882.32
R2 906.28
R3 944.57
Moving Average
20 SMA 767.91
50 SMA 743.33
100 SMA 741.91
200 SMA 808.74
Orchid Pharma Ltd Corporate Actions
No available data
Orchid Pharma Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Orchid Pharma Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Kotak Special Opportunites Fund | 1.55% |
| Kotak Consumption Fund | 1.13% |
| Quant Small Cap Fund | 0.83% |
| UTI-Value Fund | 0.54% |
| Kotak Multi Asset Allocation Fund - Reg | 0.52% |
Orchid Pharma Ltd News
Orchid Pharma to hold board meeting
On 11 November 2025
05 Nov 2025, 05:27 pm
Orchid Pharma schedules AGM
On 20 September 2025
19 Aug 2025, 05:40 pm
Orchid Pharma announces board meeting date
On 12 August 2025
06 Aug 2025, 03:11 pm
Orchid Pharma gets formal nod from Court of France for Allecra Therapeutics acquisition
Orchid Pharma said that the Court of France has pronounced the order in favour of the company, to acquire the assets of Allecra Therapeutics SAS with effect from 01 August 2025.
06 Aug 2025, 10:01 am
Orchid Pharma schedules EGM
On 26 June 2025
04 Jun 2025, 02:03 pm
Orchid Pharma Ltd Stock Analysis
- Annual revenue for Orchid Pharma Ltd increased by 12.25% to ₹953.86 crore in FY 2025 from ₹849.76 crore in FY 2024.
- Annual Net Profit for Orchid Pharma Ltd increased by 12.38% to ₹106.48 crore in FY 2025 from ₹94.75 crore in FY 2024.
- Promoter Shareholding in Orchid Pharma Ltd remains unchanged by 0.00% in the most recent quarter, from 69.84% in June 2025 to 69.84% in September 2025.
- Orchid Pharma Ltd delivered a 1-year return of -39.61% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Orchid Pharma Ltd share price moved up by 0.38% from its previous close of INR ₹858.35. The latest Orchid Pharma Ltd share price is INR ₹861.65.
- Orchid Pharma Ltd share price today has been at a low of 850 and a high of 867.10. Over the past 52 weeks, the Orchid Pharma Ltd share price has seen a low of 603.80 and a high of 1,997.40.
FAQ’s
What is the share price of Orchid Pharma Ltd today?
Orchid Pharma Ltd share price as on 18 Nov 2025 is ₹ 861.65
What is the Market Cap of Orchid Pharma Ltd?
The market cap of Orchid Pharma Ltd stock is ₹4,353.47 Cr.
What is the PE Ratio of Orchid Pharma Ltd?
The Price to Earnings (P/E) Ratio of Orchid Pharma Ltd is 37.01
What is the PB Ratio of Orchid Pharma Ltd?
The Price to Book (P/B) Ratio of Orchid Pharma Ltd is 3.14
What is the 52 week high of Orchid Pharma Ltd Share Price?
The 52 week high of Orchid Pharma Ltd share price stands at ₹1,997.40
What is the 52 week low of Orchid Pharma Ltd Share Price?
The 52 week low of Orchid Pharma Ltd share price stands at ₹603.80
How can I buy shares of Orchid Pharma Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Orchid Pharma Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
